Recent Finacing
Recent Raise
Cardiorentis is a Switzerland-based biopharma developing ularitide, a synthetic natriuretic peptide IV infusion in Phase III for acute decompensated heart failure, with protein-biology platform for peptide and small-molecule design.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor